KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 91 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $42 | -63.2% | 23,069 | -21.6% | 0.00% | – |
| Q1 2023 | $114 | +1040.0% | 29,434 | +875.6% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 3,017 | -83.1% | 0.00% | – |
| Q3 2022 | $97,000 | +592.9% | 17,855 | +491.8% | 0.00% | – |
| Q2 2022 | $14,000 | -41.7% | 3,017 | 0.0% | 0.00% | – |
| Q1 2022 | $24,000 | +26.3% | 3,017 | 0.0% | 0.00% | – |
| Q4 2021 | $19,000 | +5.6% | 3,017 | 0.0% | 0.00% | – |
| Q3 2021 | $18,000 | -41.9% | 3,017 | 0.0% | 0.00% | – |
| Q2 2021 | $31,000 | -3.1% | 3,017 | 0.0% | 0.00% | – |
| Q1 2021 | $32,000 | -31.9% | 3,017 | 0.0% | 0.00% | – |
| Q4 2020 | $47,000 | +6.8% | 3,017 | 0.0% | 0.00% | – |
| Q3 2020 | $44,000 | -22.8% | 3,017 | 0.0% | 0.00% | – |
| Q2 2020 | $57,000 | -1.7% | 3,017 | 0.0% | 0.00% | – |
| Q1 2020 | $58,000 | +1.8% | 3,017 | 0.0% | 0.00% | – |
| Q4 2019 | $57,000 | +67.6% | 3,017 | -46.9% | 0.00% | – |
| Q2 2019 | $34,000 | +3.0% | 5,686 | 0.0% | 0.00% | – |
| Q1 2019 | $33,000 | -35.3% | 5,686 | 0.0% | 0.00% | – |
| Q4 2018 | $51,000 | -47.4% | 5,686 | 0.0% | 0.00% | – |
| Q3 2018 | $97,000 | 0.0% | 5,686 | 0.0% | 0.00% | – |
| Q2 2018 | $97,000 | +340.9% | 5,686 | +242.9% | 0.00% | – |
| Q1 2018 | $22,000 | +37.5% | 1,658 | 0.0% | 0.00% | – |
| Q4 2017 | $16,000 | -11.1% | 1,658 | 0.0% | 0.00% | – |
| Q3 2017 | $18,000 | +20.0% | 1,658 | 0.0% | 0.00% | – |
| Q2 2017 | $15,000 | -28.6% | 1,658 | 0.0% | 0.00% | – |
| Q1 2017 | $21,000 | +31.2% | 1,658 | 0.0% | 0.00% | – |
| Q4 2016 | $16,000 | -50.0% | 1,658 | -50.0% | 0.00% | – |
| Q3 2016 | $32,000 | +190.9% | 3,316 | +100.0% | 0.00% | – |
| Q2 2016 | $11,000 | -26.7% | 1,658 | 0.0% | 0.00% | – |
| Q1 2016 | $15,000 | -31.8% | 1,658 | 0.0% | 0.00% | – |
| Q4 2015 | $22,000 | +22.2% | 1,658 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | -60.0% | 1,658 | 0.0% | 0.00% | – |
| Q2 2015 | $45,000 | -11.8% | 1,658 | 0.0% | 0.00% | – |
| Q1 2015 | $51,000 | -17.7% | 1,658 | 0.0% | 0.00% | – |
| Q4 2014 | $62,000 | – | 1,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |